Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Renal dopamine pathways merit targeted hypertension trials; leaves open whether modulation improves patient outcomes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Raymond C. Harris (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: